Akumentis Healthcare first synthetic CBD for epilepsy January 10, 2024 Akumentis Healthcare Limited, pharma major, has launched Clasepi – DCGI-approved prescription cannabidiol (CBD] specifically formulated to address seizures linked with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome, or... Trending Diarrhea main killer of kids under 5, adults above 70: Study How children “look” at their social environment could help predict autism diagnosis One in three men globally infected with genital HPV: Study Latest Diarrhea main killer of kids under 5, adults above 70: Study Healthy population fuels productivity, drives economic growth: Union Health Secretary NEET-UG exam soon to shift from offline to online, NTA to undergo re-structuring What is textationship: New age Romance of New Generation
